Pubblicazioni

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront

2015 - LEUKEMIA & LYMPHOMA

Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana

Eruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with ruxolitinib

2015 - BRITISH JOURNAL OF DERMATOLOGY

Fabiano, A.; Calzavara-Pinton, P.; Monari, P.; Moggio, E.; Pellacani, G.; Manganoni, A. M.; Gualdi, G.